Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

TAVR: Miracle for Some, but No Improvements in Quality of Life for Others

Yael L. Maxwell

December 22, 2016

News Conference News AHA 2016

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Yael L. Maxwell

November 21, 2016

News Conference News AHA 2016

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Shelley Wood

November 14, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

Case #1. Post-SAVR Paravalvulular Leak

Presenter: Eulogio J. Garcia, E. Murat Tuzcu

October 30, 2016

News Daily News

TAVR 3 年后瓣膜性能持稳，大多数死亡非心脏相关：FRANCE 2 登记表

Caitlin E. Cox

October 04, 2016

News Daily News

Registro FRANCE 2: 3 Años Después de una TAVR, el Rendimiento de la Válvula se Mantiene y casi Toda la Mortalidad es No Cardíaca

Caitlin E. Cox

October 04, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

较低风险患者 TAVR 后生存率优于手术组，没有“风险升高”

L.A. McKeown

August 24, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

Presentation

Comparativa de Complicaciones y Resultados al cabo de 1 Año de la TAVR frente a la SAVR en la Estenosis Aórtica Severa

Presenter: 73900|Corrado Tamburino

March 04, 2012

Presentation

Comparison of Complications and Outcomes to 1 Year of TAVR vs. SAVR in Severe Aortic Stenosis

Presenter: 73900|Corrado Tamburino

March 01, 2012

News Daily News

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Jason Kahn

November 06, 2011

Advertisement

TAVR: Miracle for Some, but No Improvements in Quality of Life for Others

“Huge Shift” Favoring Interventions in Aortic Stenosis Care May Still Omit Many Elderly Patients

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Case #1. Post-SAVR Paravalvulular Leak

TAVR 3 年后瓣膜性能持稳，大多数死亡非心脏相关：FRANCE 2 登记表

Registro FRANCE 2: 3 Años Después de una TAVR, el Rendimiento de la Válvula se Mantiene y casi Toda la Mortalidad es No Cardíaca

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

较低风险患者 TAVR 后生存率优于手术组，没有“风险升高”

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

What TAVR Needs Next . . . and What It’s Getting

TAVR Studies Tease Out Influences on Clinical Outcome

Comparativa de Complicaciones y Resultados al cabo de 1 Año de la TAVR frente a la SAVR en la Estenosis Aórtica Severa

Comparison of Complications and Outcomes to 1 Year of TAVR vs. SAVR in Severe Aortic Stenosis

Surgical, Transcatheter Valve Therapies Show Similar Long-term Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content